The information of Preventing with Experts' pipeline is only aimed at veterinary medical professionals.
Are you a health professional?

BRUCELLOSIS

OCUREV

An essential and innovative vaccine to control ovine and caprine brucellosis.

VACCINE OF CHOICE

Manufactured in compliance with OIE and EU standards, OCUREV was the first REV-1 conjunctival vaccine developed and made available. Now, it is an essential tool to control ovine and caprine brucellosis in numerous countries worldwide.

FIRST STEP IN THE CONTROL OF BRUCELLA MELITENSIS

Caprine and ovine brucellosis is a major cause of miscarriage, resulting in significant economic losses for farmers. Vaccination is a practical and effective method to reduce the incidence of brucellosis in endemic areas.

EASY OCULAR ADMINISTRATION

The Patent Blue V makes it easy to differentiate between vaccinated and non-vaccinated animals.

PERFECT DOSE PRECISION

OCUREV combines perfect dissolution of the freeze-dried cake and high dosage precision of the dropper for optimal and efficient ocular application.

LONG-LASTING PROTECTION

OCUREV offers long-lasting protection due to cell-mediated immune response, which is the principal defense mechanism against brucella disease.

Helping decrease human brucellosis

Brucellosis is highly pathogenic for humans, causing one of the most serious zoonoses in the world. Animal vaccination has been shown to reduce the zoonotic spread of the disease, leading to a notable decrease in the prevalence of human brucellosis.

PREVENTING INTERFERENCE WITH SEROLOGICAL TESTS

When OCUREV is administered via ocular route in sheep and goats aged 3 to 6 months, it induces a short-lasting serological response that avoids interference with conventional serological tests. This vaccine is compatible with eradication programs based on mass vaccination and test and slaughter principles.

Brucellosis in sheep - Preventing with experts

SUPPRESSION OF THE INFECTION PRESSURE

Vaccination results in elimination of the clinical signs (miscarriages) and the excretion of Brucella melitensis bacteria, thus reducing contamination of the environment and the spread of the disease.

Sheep and goats - Preventing with experts

STABILITY

This vaccine against brucellose is extremely stable and shows no tendency to revert virulence. OCUREV has a shelf life of 24 months, allowing prolonged storage with the same quality of protection. Investigations carried out on this vaccine indicate that it is thermostable. It can be transported and kept at a maximum of 37°C for a period not exceeding 7 days, facilitating transport for application in herds that are difficult to access.